Windows of opportunity for Ebola virus infection treatment and vaccination

Windows of opportunity for Ebola virus infection treatment and vaccination

Abstract Ebola virus (EBOV) infection causes a high death toll, killing a high proportion of EBOV-infected patients within 7 days. Comprehensive data on EBOV infection are fragmented, hampering efforts in developing therapeutics and vaccines against EBOV. Under this circumstance, mathematical models...

Full description

Bibliographic Details
Main Authors:	Van Kinh Nguyen, Esteban A. Hernandez-Vargas
Format:	Article
Language:	English
Published:	Nature Portfolio 2017-08-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-017-08884-0

Similar Items

Ebola Virus Infection Modelling and Identifiability Problems
by: Van-Kinh eNguyen, et al.
Published: (2015-04-01)

Vaccines against Ebola virus
by: Venkatraman, N, et al.
Published: (2017)

Ebola Virus Infection
by: İlkay BOZKURT, et al.
Published: (2014-12-01)

Human Antibody Repertoire following Ebola Virus Infection and Vaccination
by: Sandra Fuentes, et al.
Published: (2020-03-01)

Development and implementation of the Ebola Exposure Window Calculator: A tool for Ebola virus disease outbreak field investigations.
by: Amy Whitesell, et al.
Published: (2021-01-01)

Development and implementation of the Ebola Exposure Window Calculator: A tool for Ebola virus disease outbreak field investigations
by: Amy Whitesell, et al.
Published: (2021-01-01)

Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies
by: Supriya Ravichandran, et al.
Published: (2022-08-01)

Mechanisms of immunity in post-exposure vaccination against Ebola virus infection.
by: Steven B Bradfute, et al.
Published: (2015-01-01)

Therapeutic monoclonal antibodies for Ebola virus infection derived from vaccinated humans
by: Rijal, P, et al.
Published: (2019)

Closer than ever to an Ebola virus vaccine
by: Logan Banadyga, et al.
Published: (2017-05-01)

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells.
by: Yingyun Cai, et al.
Published: (2021-01-01)

Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors
by: Thomas R. Kreil
Published: (2015-03-01)

Ebola vaccination
by: Fitzgerald, F, et al.
Published: (2015)

High-resolution epidemic simulation using within-host infection and contact data
by: Van Kinh Nguyen, et al.
Published: (2018-07-01)

Occupational Exposures to Ebola Virus in Ebola Treatment Center, Conakry, Guinea
by: Hélène Savini, et al.
Published: (2017-08-01)

Vaccines for Ebola
by: Editorial Article
Published: (2015-02-01)

Experimental vaccine protects monkeys against Ebola virus
by: Scott Gottlieb

Persistence of immune responses induced by Ebola virus vaccines
by: Matthew D Snape
Published: (2017-03-01)

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
by: Thomas W. Geisbert, et al.
Published: (2002-05-01)

Current state of Ebola virus vaccines: A snapshot
by: Courtney Woolsey, et al.
Published: (2021-12-01)

Persistence of immune responses induced by Ebola virus vaccines.
by: Snape, M
Published: (2017)

SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus
by: Jordana Muñoz-Basagoiti, et al.
Published: (2021-01-01)

Interferon-γ Inhibits Ebola Virus Infection.
by: Bethany A Rhein, et al.
Published: (2015-01-01)

CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected Cells
by: Hiroyuki Mori, et al.
Published: (2022-08-01)

Modeling Challenges of Ebola Virus–Host Dynamics during Infection and Treatment
by: Daniel S. Chertow, et al.
Published: (2020-01-01)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
by: Andrea Marzi, et al.
Published: (2015-02-01)

Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo
by: Neil Rupani, et al.
Published: (2022-06-01)

Therapeutic Strategies against Ebola Virus Infection
by: Ching-Hsuan Liu, et al.
Published: (2022-03-01)

Host Transcriptional Response to Ebola Virus Infection
by: Emily Speranza, et al.
Published: (2017-09-01)

Predicting Ebola infection: A malaria-sensitive triage score for Ebola virus disease.
by: Mary-Anne Hartley, et al.
Published: (2017-02-01)

In silico-based vaccine design against Ebola virus glycoprotein
by: Dash R, et al.
Published: (2017-03-01)

In silico-based vaccine design against Ebola virus glycoprotein
by: Dash, R., et al.
Published: (2017)

Detection of vaccine-induced antibodies to Ebola virus in oral fluid
by: Lambe, T, et al.
Published: (2016)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
by: Emmie de Wit, et al.
Published: (2015-04-01)

Ebola Virus Disease Vaccines: Development, Current Perspectives & Challenges
by: Sumira Malik, et al.
Published: (2023-01-01)

Experimental treatment of Ebola virus disease with brincidofovir
by: Dunning, J, et al.
Published: (2016)

Vaccines to prevent Ebola virus disease: current challenges and perspectives
by: Anna V. Kovyrshina, et al.
Published: (2023-11-01)

Identification of Novel Adjuvants for Ebola Virus-Like Particle Vaccine
by: Huapeng Feng, et al.
Published: (2020-05-01)

Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease
by: Adam J. Kucharski, et al.
Published: (2016-01-01)

Ebolavirus Vaccines: Progress in the Fight Against Ebola Virus Disease
by: Xiao-Xin Wu, et al.
Published: (2015-11-01)